Jagsonpal Pharmaceuticals Limited

NSEI:JAGSNPHARM 주식 보고서

시가총액: ₹15.7b

Jagsonpal Pharmaceuticals 미래 성장

Future 기준 확인 0/6

현재 Jagsonpal Pharmaceuticals 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Pharmaceuticals 수익 성장17.7%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

None

마지막 업데이트n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Some Confidence Is Lacking In Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) P/E

Oct 14
Some Confidence Is Lacking In Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) P/E

There May Be Some Bright Spots In Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Earnings

May 27
There May Be Some Bright Spots In Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Earnings

There's Reason For Concern Over Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Massive 27% Price Jump

Apr 30
There's Reason For Concern Over Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Massive 27% Price Jump

A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Apr 05
A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Investor Optimism Abounds Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) But Growth Is Lacking

Feb 06
Investor Optimism Abounds Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) But Growth Is Lacking

Estimating The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jul 29
Estimating The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

A Look At The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

May 13
A Look At The Intrinsic Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Does Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Deserve A Spot On Your Watchlist?

Jul 05
Does Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Deserve A Spot On Your Watchlist?

A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jun 13
A Look At The Fair Value Of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) 0.6% Dividend Yield Looks Pretty Interesting

Apr 19
Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) 0.6% Dividend Yield Looks Pretty Interesting

Should You Be Adding Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) To Your Watchlist Today?

Mar 21
Should You Be Adding Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) To Your Watchlist Today?

Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Stock Is Going Strong: Have Financials A Role To Play?

Feb 08
Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) Stock Is Going Strong: Have Financials A Role To Play?

The Attractive Combination That Could Earn Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) A Place In Your Dividend Portfolio

Jan 08
The Attractive Combination That Could Earn Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) A Place In Your Dividend Portfolio

Here's Why I Think Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Is An Interesting Stock

Dec 21
Here's Why I Think Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Is An Interesting Stock

Are Jagsonpal Pharmaceuticals's (NSE:JAGSNPHARM) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 30
Are Jagsonpal Pharmaceuticals's (NSE:JAGSNPHARM) Statutory Earnings A Good Reflection Of Its Earnings Potential?

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Jagsonpal Pharmaceuticals 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

NSEI:JAGSNPHARM - 애널리스트의 미래 추정치 및 과거 재무 데이터 (INR Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
9/30/20242,269243573575N/A
6/30/20242,100203N/AN/AN/A
3/31/20242,087225349352N/A
12/31/20232,207245N/AN/AN/A
9/30/20232,336283492498N/A
6/30/20232,363313N/AN/AN/A
3/31/20232,367267463467N/A
12/31/20222,410223N/AN/AN/A
9/30/20222,348198-2-1N/A
6/30/20222,326131N/AN/AN/A
3/31/20222,1761895969N/A
12/31/20212,168247N/AN/AN/A
9/30/20212,194247308316N/A
6/30/20212,163214N/AN/AN/A
3/31/20211,879171278282N/A
12/31/20201,746135N/AN/AN/A
9/30/20201,595104200210N/A
6/30/20201,45084N/AN/AN/A
3/31/20201,58679100119N/A
12/31/20191,67593N/AN/AN/A
9/30/20191,67388N/AN/AN/A
6/30/20191,69785N/AN/AN/A
3/31/20191,66872286309N/A
12/31/20181,61130N/AN/AN/A
9/30/20181,573-10N/AN/AN/A
6/30/20181,421-66N/AN/AN/A
3/31/20181,266-116N/A-16N/A
12/31/20171,234-95N/AN/AN/A
9/30/20171,19326N/AN/AN/A
6/30/20171,30570N/AN/AN/A
4/1/20171,441119N/A-32N/A
12/31/20161,534131N/AN/AN/A
9/30/20161,53735N/AN/AN/A
6/30/20161,46634N/AN/AN/A
3/31/20161,43533N/A90N/A
12/31/20151,43413N/AN/AN/A
9/30/20151,41210N/AN/AN/A
6/30/20151,4129N/AN/AN/A
3/31/20151,38212N/A43N/A
12/31/20141,30623N/AN/AN/A
9/30/20141,35932N/AN/AN/A
6/30/20141,39728N/AN/AN/A
3/31/20141,43921N/A75N/A
12/31/20131,50712N/AN/AN/A

애널리스트 미래 성장 예측

수입 대 저축률: JAGSNPHARM 의 예상 수익 증가율이 절약률( 6.7% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: JAGSNPHARM 의 수익이 Indian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: JAGSNPHARM 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: JAGSNPHARM 의 수익이 Indian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: JAGSNPHARM 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: JAGSNPHARM 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y